Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Populations news

Show

From To
Most meth users too embarrassed to seek treatment

The biggest barriers to methamphetamine users seeking treatment are embarrassment or stigma, belief that help is not needed, preferring to withdraw without help and privacy concerns, according to a new study.

Published
01 November 2016
From
University of Western Australia
PrEP for African migrants in Europe? A research agenda

Clinical trials and demonstration projects in Europe have focused solely on men having sex with men (MSM). In contrast to global PrEP research, Europe seems to have overlooked heterosexuals at risk of HIV, mostly sub-Saharan African migrants and other ethnic minorities from endemic regions. Research should urgently investigate how to offer PrEP to all people in need: how to stimulate demand, how to deliver it, and how to support adherence.

Published
31 October 2016
From
The Lancet HIV (requires free registration)
Only a small proportion of gay men with HIV receive anal cancer screening

In the absence of national screening guidelines, only 11% of HIV-positive gay and bisexual men in the US received anal pap smears to detect anal cancer or

Published
31 October 2016
By
Liz Highleyman
Maintenance prescribing saves lives of English heroin addicts

To prevent overdose deaths, engage and retain people dependent on heroin or similar drugs in substitute prescribing programmes like methadone maintenance, is the clear implication of this English study. And watch out for them after leaving, especially after residential rehabilitation or inpatient care, when the death rate peaked at nearly 19 per 1000 person-years.

Published
30 October 2016
From
Drug & Alcohol Findings
HIVR4P 2016: Services for female sex workers show low cost impact

Presentations this morning highlighted efforts to reach female sex workers with data from studies in South Africa, Rwanda and Kenya that provided HIV self-testing, antiretroviral treatment, pre-exposure prophylactic use of antiretroviral drugs — PrEP — and other services.

Published
27 October 2016
From
Science Speaks
Tests of online PrEP purchases by London clinic find no fakes, and adequate drug levels

A sexual health clinic in central London that offered to test drug levels in users of tenofovir/emtricitabine pre-exposure prophylaxis (PrEP) who had bought it online found adequate

Published
26 October 2016
By
Gus Cairns
This Isn't Just Research, It's Our Lives: Centering Trans Stories In HIV Treatment & Prevention

I have been growing increasingly frustrated with the lack of institutional foresight on prioritizing research specific to transgender people and our experiences with HIV. Transgender people are living with or at significantly higher risk of contracting HIV than the general population. But research on trans experiences of HIV is only just gaining momentum in large research institutions.

Published
26 October 2016
From
AIDS United
Researchers find people who inject drugs would be willing to switch to safer equipment

People who inject drugs support the use of new, safer ‘low dead space’ syringes, NIHR-funded researchers from the University of Bristol have found. Research suggests that these low dead space syringes could reduce the chance of spreading infections among people who inject drugs, if syringes are re-used or shared, so are a safer alternative to traditional equipment.

Published
26 October 2016
From
National Institute for Health Research
Some of the Americans who need PrEP the most face the greatest barriers to getting it

The personal values and moral judgements of healthcare providers are likely to interfere with the appropriate provision of pre-exposure prophylaxis (PrEP), Sarah Calabrese of Yale University told

Published
25 October 2016
By
Roger Pebody
Rings, films or inserts? Researchers need to develop prevention products that make sense in women’s lives

“We need to think outside of the box,” Sharon Hillier of the Microbicide Trials Network told the HIV Research for Prevention (HIVR4P 2016) conference in Chicago

Published
21 October 2016
By
Roger Pebody

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.